Disease | neutropenia |
Phenotype | C0019204|hepatocellular carcinoma |
Sentences | 1 |
PubMedID- 25711511 | Adding three patients for confirmation was abandoned owing to the drug safety update from the metiv-hcc study, in which higher incidence of neutropenia was reported in patients with hepatocellular carcinoma (hcc) treated with 240 mg bid as the tablet formulation.13 em, extensive metabolizers; pm, poor metabolizers. |
Page: 1